Implications of salivary protein binding to commensal and pathogenic bacteria

Journal of Oral Biosciences

Volumn 55, Issue 4, 2013, Pages 169-174

  Heoa, Seok Mo ^a,b   Ruhla, Stefan ^a   Scannapieco, Frank A ^a  

^a UNIVERSITY AT BUFFALO   (United States)

^b Chonbuk National University   (South Korea)

Author keywords

Saliva Microbial adhesion Biofilm Oral diseases

Indexed keywords

EID: 84892616326     PISSN: 13490079     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.job.2013.06.004     Document Type: Review

References (132)

1. Marsh PD. Dental plaque as a biofilm and a microbial community? implications for health and disease. BMC Oral Health 2006;6(Suppl. 1):S14.
2. Bik EM, Long CD, Armitage GC, Loomer P, Emerson J, Mongodin EF, Nelson KE, Gill SR, Fraser-Liggett CM, Relman DA. Bacterial diversity in the oral cavity of 10 healthy individuals. ISME J 2010;4:962-74.
3. Dewhirst FE, Chen T, Izard J, Paster BJ, Tanner AC, Yu WH, Lakshmanan A, Wade WG. The human oral microbiome. J Bacteriol 2010;192:5002-17.
4. Jenkinson HF. Beyond the oral microbiome. Environ Microbiol 2011;13: 3077-3087.
5. Griffen AL, Beall CJ, Firestone ND, Gross EL, Difranco JM, Hardman JH, Vriesendorp B, Faust RA, Janies DA, Leys EJ. CORE: a phylogenetically-curated 16S rDNA database of the core oral microbiome. PLoS One 2011;6:e19051.
6. Dahlen G. Non-odontogenic infections in dentistry. Periodontology 2000 2009;49:7-12.
7. Slots J, Slots H. Bacterial and viral pathogens in saliva: disease relationship and infectious risk. Periodontology 2000 2011;55:48-69.
8. Ross PW. Quantitative studies on the salivary flora. J Clin Pathol 1971;24:717-20.
9. Dowsett SA, Kowolik MJ. Oral Helicobacter pylori: can we stomach it? Crit Rev Oral Biol Med 2003;14:226-33.
10. Zou QH, Li RQ. Helicobacter pylori in the oral cavity and gastric mucosa: a meta-analysis. J Oral Pathol Med 2011;40:317-24.
11. Burgers R, Schneider-Brachert W, Reischl U, Behr A, Hiller KA, Lehn N, Schmalz G, Ruhl S. Helicobacter pylori in human oral cavity and stomach. Eur J Oral Sci 2008;116:297-304.
12. Kroes I, Lepp PW, Relman DA. Bacterial diversity within the human subgingival crevice. Proc Natl Acad Sci USA 1999;96:14547-52.
13. Scannapieco FA, Stewart EM, Mylotte JM. Colonization of dental plaque by respiratory pathogens in medical intensive care patients. Crit Care Med 1992;20:740-5.
14. Scannapieco FA. Role of oral bacteria in respiratory infection. J Periodontol 1999;70:793-802.
15. Senpuku H, Sogame A, Inoshita E, Tsuha Y, Miyazaki H, Hanada N. Systemic diseases in association with microbial species in oral biofilm from elderly requiring care. Gerontology 2003;49:301-9.
16. Didilescu AC, Skaug N, Marica C, Didilescu C. Respiratorypathogens in dental plaque of hospitalized patients with chronic lung diseases. Clin Oral Invest 2005;9:141-7.
17. Scannapieco FA, Mylotte JM. Relationships between periodontal disease and bacterial pneumonia. J Periodontol 1996;67:1114-22.
18. Terpenning MS, Taylor GW, Lopatin DE, Kerr CK, Dominguez BL, Loesche WJ. Aspiration pneumonia: dental and oral risk factors in an older veteran population. J Am Geriatr Soc 2001;49:557-63.
19. Heo SM, Haase EM, Lesse AJ, Gill SR, Scannapieco FA. Genetic relationships between respiratory pathogens isolated from dental plaque and bronchoal- veolar lavage fluid from patients in the intensive care unit undergoing mechanical ventilation. Clin Infect Dis 2008;47:1562-70.
20. Etienne J, Fleurette J, Ninet JF, Favet P, Gruer LD. Staphylococcal endocarditis after dental extraction. Lancet 1986;2:511-2.
21. Scannapieco FA, Stewart EM, Mylotte JM. Colonization of dental plaque by respiratory pathogens in medical intensive care patients. Crit Care Med 1992;20:740-5.
22. Mandel ID. The functions of saliva. J Dent Res 1987;66:623-7.
23. Helmerhorst EJ, Oppenheim FG. Saliva: a dynamic proteome. J Dent Res 2007;86:680-93.
24. Scannapieco FA. Saliva-bacterium interactions in oral microbial ecology. Crit Rev Oral Biol Med 1994;5:203-48.
25. Amerongen AV, Veerman EC. Saliva?the defender of the oral cavity. Oral Dis 2002;8:12-22.
26. Ruhl S. The scientific exploration of saliva in the post-proteomic era: from database back to basic function. Expert Rev Proteomics 2012;9:85-96.
27. Geetha C, Venkatesh SG, Bingle L, Bingle CD, Gorr SU. Design and validation of anti-inflammatory peptides from human parotid secretory protein. J Dent Res 2005;84:149-53.
28. Gorr SU. Antimicrobial peptides of the oral cavity. Periodontology 2000 2009;51:152-80.
29. Wei GX, Campagna AN, Bobek LA. Effect of MUC7 peptides on the growth of bacteria and on Streptococcus mutans biofilm. J Antimicrob Chemother 2006;57:1100-9.
30. De Smet K, Contreras R. Human antimicrobial peptides: defensins, cathe- licidins and histatins. Biotechnol Lett 2005;27:1337-47.
31. Schenkels LC, Veerman EC, Nieuw Amerongen AV. Biochemical composition of human saliva in relation to other mucosal fluids. Crit Rev Oral Biol Med 1995;6:161-75.
32. Oppenheim FG, Xu T, McMillian FM, Levitz SM, Diamond RD, Offner GD, Troxler RF. Histatins, a novel family of histidine-rich proteins in human parotid secretion. Isolation, characterization, primary structure, and fungi-static effects on Candida albicans. J Biol Chem 1988;263:7472-7.
33. Jang WS, Li XS, Sun JN, Edgerton M. The P-113 fragment of histatin 5 requires a specific peptide sequence for intracellular translocation in Candida albicans, which is independent of cell wall binding. Antimicrob Agents Che- mother 2008;52:497-504.
34. Soukka T, Tenovuo J, Lenander-Lumikari M. Fungicidal effect of human lactoferrin against Candida albicans. FEMS Microbiol Lett 1992;69:223-8.
35. Wakabayashi H, Kondo I, Kobayashi T, Yamauchi K, Toida T, Iwatsuki K, Yoshie H. Periodontitis, periodontopathic bacteria and lactoferrin. Biometals 2010;23:419-24.
36. Bratthall D, Gibbons RJ. Changing agglutination activities of salivary immu-noglobulin A preparations against oral streptococci. Infect Immun 1975;11:603-6.
37. Levine MJ, Herzberg MC, Levine MS, Ellison SA, Stinson MW, Li HC, van Dyke T. Specificity of salivary-bacterial interactions: role of terminal sialic acid residues in the interaction of salivary glycoproteins with Streptococcus sanguis and Streptococcus mutans. Infect Immun 1978;19:107-15.
38. Rundegren J, Ericson T. Effect of calcium on reactions between a salivary agglutinin and a serotype c strain of Streptococcus mutans. J Oral Pathol 1981;10:269-75.
39. Rundegren J. Calcium-dependent salivary agglutinin with reactivity to various oral bacterial species. Infect Immun 1986;53:173-8.
40. Ligtenberg AJ, Veerman EC, Nieuw Amerongen AV, Mollenhauer J. Salivary agglutinin/glycoprotein-340/DMBT1: a single molecule with variable composition and with different functions in infection, inflammation and cancer. Biol Chem 2007;388:1275-89.
41. Leito JT, Ligtenberg AJ, Nazmi K, de Blieck-Hogervorst JM, Veerman EC, Nieuw Amerongen AV. A common binding motif for various bacteria of the bacteria-binding peptide SRCRP2 of DMBT1/gp-340/salivary agglutinin. Biol Chem 2008;389:1193-200.
42. Ruhl S, Sandberg AL, Cisar JO. Salivary receptors for the proline-rich protein-binding and lectin-like adhesins of oral actinomyces and streptococci. JDent Res 2004;83:505-10.
43. Takamatsu D, Bensing BA, Prakobphol A, Fisher SJ, Sullam PM. Binding of the streptococcal surface glycoproteins GspB and Hsa to human salivary proteins. Infect Immun 2006;74:1933-40.
44. Dennesen P, van der Ven A, Vlasveld M, Lokker L, Ramsay G, Kessels A, van den Keijbus P, van Nieuw Amerongen A, Veerman E. Inadequate salivary flow and poor oral mucosal status inintubated intensive care unit patients. Crit Care Med 2003;31:781-6.
45. Bostrom M, Williams DR Ninham BW. Specific ion effects: why the properties of lysozyme in salt solutions follow a Hofmeister series. Biophys J 2003;85:686-94.
46. Bostrom M, Williams DR, Ninham BW. Specific ion effects: role of salt and buffer in protonation of cytochrome c. Eur Phys J E Soft Matter 2004;13:239-45.
47. Perutz MF. Electrostatic effects in proteins. Science 1978;201:1187-91.
48. Katsikogianni M, Missirlis YF. Concise review of mechanisms of bacterial adhesion to biomaterials and of techniques used in estimating bacteria- material interactions. Eur Cells Mater 2004;8:37-57.
49. Bennion BJ, Daggett V. The molecular basis for the chemical denaturation of proteins by urea. Proc Natl Acad Sci USA 2003;100:5142-7.
50. Eissa AS, Khan SA. Modulation of hydrophobic interactions in denatured whey proteins by transglutaminase enzyme. Food Hydrocollids 2006;20:543-7.
51. Levine MJ, Reddy MS, Tabak LA, Loomis RE, Bergey EJ, Jones PC, Cohen RE, Stinson MW, Al-Hashimi I. Structural aspects of salivary glycoproteins. JDent Res 1987;66:436-41.
52. Duncan-Hewitt WC. Nature of the hydrophobic effect. In: Microbial Cell Surface Hydrophobicity: ASM Publications; 1990. p. 39-73.
53. van Oss CJ. Hydrophobicity and hydrophilicity of biosurfaces. Curr Opinion Colloid Interface Sci 1997;2:503-12.
54. Brack CM, Reynolds EC. Characterization of a rat salivary sialoglycoprotein complex which agglutinates Streptococcus mutans. Infect Immun 1987;55:1264-73.
55. Chang JY. Structural heterogeneity of 6M. GdmCl-denatured proteins: implications for the mechanism of protein folding. Biochemistry 2009;48:9340-6.
56. Monera OD, Kay CM, Hodges RS. Protein denaturation with guanidine hydrochloride or urea provides a different estimate of stability depending on the contributions ofelectrostatic interactions. Protein Sci 1994;3:1984-91.
57. Tanford C. Protein denaturation. C. Theoretical models for the mechanism of denaturation. Adv Protein Chem 1970;24:1-95.
58. Hanakam F, Gerisch G, Lotz S, Alt T, Seelig A. Binding of hisactophilin I and II to lipid membranes is controlled by a pH-dependent myristoyl-histidine switch. Biochemistry 1996;35:11036-44.
59. Ben-Tal N, Honig B, Miller C, McLaughlin S. Electrostatic binding of proteins to membranes. Theoretical predictions and experimental results with charybdotoxin and phospholipid vesicles. Biophys J 1997;73:1717-27.
60. Sankaram MB, Brophy PJ, Marsh D. Lipid-protein and protein-protein interactions in double recombinants of myelin proteolipid apoprotein and myelin basic protein with dimyristoylphosphatidylglycerol. Biochemistry 1991;30:5866-73.
61. Busscher HJ, Norde W, van der Mei HC. Specific molecular recognition and nonspecific contributions to bacterial interaction forces. Appl Environ Microbiol 2008;74:2559-64.
62. Gibbons RJ, van Houte J. Selective bacterial adherence to oral epithelial surfaces and its role as an ecological determinant. Infect Immun 1971;3:567-73.
63. Nobbs AH, Jenkinson HF, Jakubovics NS. Stick to your gums: mechanisms of oral microbial adherence. J Dent Res 2011;90:1271-8.
64. Takahashi Y, Sandberg AL, Ruhl S, Muller J, Cisar JO. A specific cell surface antigen of Streptococcus gordonii is associated with bacterial hemagglutina-tion and adhesion to alpha2-3-linked sialic acid-containing receptors. Infect Immun 1997;65:5042-51.
65. Takahashi Y, Konishi K, Cisar JO, Yoshikawa M. Identification and characterization of hsa, the gene encoding the sialic acid-binding adhesin of Streptococcus gordonii DL1. Infect Immun 2002;70:1209-18.
66. Bensing BA, Siboo IR, Sullam PM. Glycine residues in the hydrophobic core of the GspB signal sequence route export toward the accessory Sec pathway. J Bacteriol 2007;189:3846-54.
67. Rose L, Shivshankar P, Hinojosa E, Rodriguez A, Sanchez CJ, Orihuela CJ. Antibodies against PsrP, a novel Streptococcus pneumoniae adhesin, block adhesion and protect mice against pneumococcal challenge. J Infect Dis 2008;198:375-83.
68. Sheen TR, Jimenez A, Wang NY, Banerjee A, van Sorge NM, Doran KS. Serine-rich repeat proteins and pili promote Streptococcus agalactiae colonization of the vaginal tract. J Bacteriol 2011;193:6834-42.
69. Siboo IR, Chambers HF, Sullam PM. Role of SraP, a Serine-Rich Surface Protein of Staphylococcus aureus, in binding to human platelets. Infect Immun 2005;73:2273-80.
70. Lizcano A, Sanchez CJ, Orihuela CJ. A role for glycosylated serine-rich repeat proteins in gram-positive bacterial pathogenesis. Mol Oral Microbiol 2012;27:257-69.
71. Lofling J, Vimberg V, Battig P, Henriques-Normark B. Cellular interactions by LPxTG-anchored pneumococcal adhesins and their streptococcal homolo-gues. Cell Microbiol 2011;13:186-97.
72. Zhou M, Wu H. Glycosylation and biogenesis of a family of serine-rich bacterial adhesins. Microbiology 2009;155:317-27.
73. Bensing BA, Sullam PM. An accessory sec locus of Streptococcus gordonii is required for export of the surface protein GspB and for normal levels of binding to human platelets. Mol Microbiol 2002;44:1081-94.
74. Ruhl S, Sandberg AL, Cole MF, Cisar JO. Recognition of immunoglobulin A1 by oral actinomyces and streptococcal lectins. Infect Immun 1996;64:5421-4.
75. Sanchez CJ, Shivshankar P, Stol K, Trakhtenbroit S, Sullam PM, Sauer K, Hermans PW, Orihuela CJ. The pneumococcal serine-rich repeat protein is an intra-species bacterial adhesin that promotes bacterial aggregation in vivo and in biofilms. PLoS Pathog 2010;6:e1001044.
76. Brady LJ, Maddocks SE, Larson MR, Forsgren N, Persson K, Deivanayagam CC, Jenkinson HF. The changing faces of Streptococcus antigen I/II polypeptide family adhesins. Mol Microbiol 2010;77:276-86.
77. Maddocks SE, Wright CJ, Nobbs AH, Brittan JL, Franklin L, Stromberg N, et al. Streptococcus pyogenes antigen I/II-family polypeptide AspA shows differential ligand-binding properties and mediates biofilm formation. Mol Microbiol 2011;81:1034-49.
78. Nikitkova AE, Haase EM, Scannapieco FA. Taking the starch out of oral biofilm formation: molecular basis and functional significance of salivary alpha-amylase binding to oral Streptococci. Appl Environ Microbiol 2013;79: 416-423.
79. Scannapieco FA, Torres G, Levine MJ. Salivary alpha-amylase: role in dental plaque and caries formation. Crit Rev Oral Biol Med 1993;4:301-7.
80. Douglas CW. The binding of human salivary alpha-amylase by oral strains of streptococcal bacteria. Arch Oral Biol 1983;28:567-73.
81. Scannapieco FA, Bergey EJ, Reddy MS, Levine MJ. Characterization of salivary alpha-amylase binding to Streptococcus sanguis. Infect Immun 1989;57:2853-63.
82. Douglas CW, Pease AA, Whiley RA. Amylase-binding as a discriminator among oral streptococci. FEMS Microbiol Lett 1990;54:193-7.
83. Kilian M, Nyvad B. Ability to bind salivary alpha-amylase discriminates certain viridans group streptococcal species. J Clin Microbiol 1990;28:2576-7.
84. Scannapieco FA, Solomon L, Wadenya RO. Emergence in human dental plaque and host distribution of amylase-binding streptococci. J Dent Res 1994;73:1627-35.
85. Gwynn JP, Douglas CW. Comparison of amylase-binding proteins in oral streptococci. FEMS Microbiol Lett 1994;124:373-9.
86. Scannapieco FA, Haraszthy GG, Cho MI, Levine MJ. Characterization of an amylase-binding component of Streptococcus gordonii G9B. Infect Immun 1992;60:4726-33.
87. Rogers JD, Palmer Jr. RJ, Kolenbrander PE, Scannapieco FA. Role of Streptococcus gordonii amylase-binding protein A in adhesion to hydroxyapatite, starch metabolism, and biofilm formation. Infect Immun 2001;69:7046-56.
88. Chaudhuri B, Paju S, Haase EM, Vickerman MM, Tanzer JM, Scannapieco FA. Amylase-binding protein B of Streptococcus gordonii is an extracellular dipeptidyl-peptidase. Infect Immun 2008;76:4530-7.
89. Tanzer JM, Grant L, Thompson A, Li L, Rogers JD, Haase EM, Scannapieco FA. Amylase-binding proteins A (AbpA) and B (AbpB) differentially affect colonization of rats' teeth by Streptococcus gordonii. Microbiology 2003;149:2653-60.
90. Nikitkova AE, Haase EM, Vickerman MM, Gill SR, Scannapieco FA. Response of fatty acid synthesis genes to the binding of human salivary amylase by Streptococcus gordonii. Appl Environ Microbiol 2012;78:1865-75.
91. Shelburne 3rd SA, Sumby P, Sitkiewicz I, Granville C, DeLeo FR, Musser JM. Central role of a bacterial two-component gene regulatory system of previously unknown function in pathogen persistence in human saliva. Proc Natl Acad Sci USA 2005;102:16037-42.
92. Melzer M, Eykyn SJ, Gransden WR, Chinn S. Is methicillin-resistant Staphylococcus aureus more virulent than methicillin-susceptible S. aureus?A comparative cohort study of British patients with nosocomial infection and bacteremia Clin Infect Dis 2003;37:1453-60.
93. Fry DE, Barie PS. The changing face of Staphylococcus aureus: a continuing surgical challenge. Surg Infect 2011;12:191-203.
94. Wertheim HF, Melles DC, Vos MC, van Leeuwen W, van Belkum A, Verbrugh HA, Nouwen JL. The role of nasal carriage in Staphylococcus aureus infections. Lancet Infect Dis 2005;5:751-62.
95. Stillwell M, Caplan ES. The septic multiple-trauma patient. Infect Dis Clin North Am 1989;3:155-83.
96. Klevens RM, Edwards JR, Tenover FC, McDonald LC, Horan T, Gaynes R. Changes in the epidemiology of methicillin-resistant Staphylococcus aureus in intensive care units in US hospitals, 1992-2003. Clin Infect Dis 2006;42:389-91.
97. Jones RN. Microbial etiologies of hospital-acquired bacterial pneumonia and ventilator-associated bacterial pneumonia. Clin Infect Dis 2010;51(Suppl. 1): S81-S87.
98. Knighton HT. Relative constancy of specific bacteriophage patterns of staphylococci isolated from oral and nasal areas. J Dent Res 1962;41:701-6.
99. Singer AJ. Salivary bacteria. III. The pathogenicity of oral staphylococci. J Dent Res 1952;31:591-7.
100. Fritschi BZ, Albert-Kiszely A, Persson GR. Staphylococcus aureus and other bacteria in untreated periodontitis. J Dent Res 2008;87:589-93.
101. Fine DH. Microbial identification and antibiotic sensitivity testing, an aid for patients refractory to periodontal therapy. A report of 3 cases. J Clin Period- ontol 1994;21:98-106.
102. Rams TE, Feik D, Slots J. Staphylococci in human periodontal diseases. Oral Microbiol Immunol 1990;5:29-32.
103. Persson GR, Samuelsson E, Lindahl C, Renvert S. Mechanical non-surgical treatment of peri-implantitis: a single-blinded randomized longitudinal clinical study. II. Microbiological results. J Clin Periodontol 2010;37:563-73.
104. Reader CM, Boniface M, Bujanda-Wagner S. Refractory endodontic lesion associated with Staphylococci aureus. J Endodontics 1994;20:607-9.
105. Rokadiya S, Malden NJ. An implant periapical lesion leading to acute osteomyelitis with isolation of Staphylococcus aureus. Br Dent J 2008;205:489-91.
106. Smith AJ, Jackson MS, Bagg J. The ecology of Staphylococcus species in the oral cavity. J Med Microbiol 2001;50:940-6.
107. Jacobson JJ, Patel B, Asher G, Woolliscroft JO, Schaberg D. Oral staphylococcus in older subjects with rheumatoid arthritis. JAm Geriatr Soc 1997;45:590-3.
108. Jobbins J, Bagg J, Parsons K, Finlay I, Addy M, Newcombe RG. Oral carriage of yeasts, coliforms and staphylococci in patients with advanced malignant disease. J Oral Pathol Med 1992;21:305-8.
109. Cruz ED, Pimenta FC, Hayashida M, Eidt M, Gir E. Staphylococcus aureus detection in the mouth of housekeepers. Rev Lat-Am Enfermagem 2011;19:90-6.
110. de Moura JP, Pimenta FC, Hayashida M, Cruz ED, Canini SR, Gir E. Colonization of nursing professionals by Staphylococcus aureus. Rev Lat-Am Enfermagem 2011;19:325-31.
111. Jackson MS, Bagg J, Gupta MN, Sturrock RD. Oral carriage of staphylococci in patients with rheumatoid arthritis. Rheumatology (Oxford) 1999;38:572-5.
112. Miyake Y, Iwai T, Sugai M, Miura K, Suginaka H, Nagasaka N. Incidence and characterization of Staphylococcus aureus from the tongues of children. JDent Res 1991;70:1045-7.
113. Millar MR, Walsh TR, Linton CJ, Zhang S, Leeming JP, Bennett PM. Carriage of antibiotic-resistant bacteria by healthy children. J Antimicrob Chemother 2001;47:605-10.
114. Biesbrock AR, Reddy MS, Levine MJ. Interaction of a salivary mucin-secretory immunoglobulin A complex with mucosal pathogens. Infect Immun 1991;59:3492-7.
115. Heo SM, Choi KS, Kazim LA, Reddy MS, Haase EM, Scannapieco FA, Ruhl S. Host defense proteins derived from human saliva bind to Staphylococcus aureus. Infect Immun 2013;81:1364-73.
116. Kukita K, Kawada-Matsuo M, Oho T, Nagatomo M, Oogai Y, Hashimoto M, Suda Y, Tanaka T, Komatsuzawa H. Staphylococcus aureus SasA is responsible for binding to salivary agglutinin, gp340, derived from human saliva. Infect Immun 2013.
117. Foster TJ, Hook M. Surface protein adhesins of Staphylococcus aureus. Trends Microbiol 1998;6:484-8.
118. Verwey WF. A type-specific antigenic protein derived from the Staphylococcus. J Exp Med 1940;71:635-44.
119. Jensen K. A normally occurring Staphylococcus antibody in human serum. Acta Pathol Microbiol Scand 1958;44:421-8.
120. Easmon CSF, Adlam C. Staphylococci and staphylococcal infections. New York: Academic Press, Inc.; 1983.
121. Cheung AL, Eberhardt K, Heinrichs JH. Regulation of protein A synthesis by the sar and agr loci of Staphylococcus aureus. Infect Immun 1997;65:2243-9.
122. Forsgren A. Protein A from Staphylococcus aureus. 8. Production of protein A by bacterial and L-forms of S. aureus. Acta Pathol Microbiol Scand 1969;75:481-90.
123. Cheung AL, Bayer AS, Peter J, Ward JI. Surface proteins of Staphylococcus aureus. Rev Infect Dis 1988;10(Suppl. 2):S351-5.
124. Kronvall G, Seal US, Finstad J, Williams Jr RC. Phylogenetic insight into evolution of mammalian Fc fragment of gamma G globulin using staphylo- coccal protein A. J Immunol 1970;104:140-7.
125. Inganas M. Comparison of mechanisms of interaction between protein A from Staphylococcus aureus and human monoclonal IgG, IgA and IgM in relation to the classical Fc gamma and the alternative F(ab')2 epsilon protein A interactions. Scand J Immunol 1981;13:343-52.
126. Sasso EH, Silverman GJ, Mannik M. Human IgM molecules that bind staphylococcal protein A contain VHIII H chains. J Immunol 1989;142:2778-83.
127. O'Seaghdha M, van Schooten CJ, Kerrigan SW, Emsley J, Silverman GJ, Cox D, Lenting PJ, Foster TJ. Staphylococcus aureus protein A binding to von Will-ebrand factor A1 domain is mediated by conserved IgG binding regions. FEBS J 2006;273:4831-41.
128. Hartleib J, Kohler N, Dickinson RB, Chhatwal GS, Sixma JJ, Hartford OM, Foster TJ, Peters G, Kehrel BE, Herrmann M. Protein A is the von Willebrand factor binding protein on Staphylococcus aureus. Blood 2000;96:2149-56.
129. Gomez MI, Lee A, Reddy B, Muir A, Soong G, Pitt A, Cheung A, Prince A. Staphylococcus aureus protein A induces airway epithelial inflammatory responses by activating TNFR1. Nat Med 2004;10:842-8.
130. Gomez MI, O'Seaghdha M, Magargee M, Foster TJ, Prince AS. Staphylococcus aureus protein A activates TNFR1 signaling through conserved IgG binding domains. J Biol Chem 2006;281:20190-6.
131. Gomez MI, Seaghdha MO, Prince AS. Staphylococcus aureus protein A activates TACE through EGFR-dependent signaling. EMBO J 2007;26:701-9.
132. Soong G, Martin FJ, Chun J, Cohen TS, Ahn DS, Prince A. Staphylococcus aureus protein A mediates invasion across airway epithelial cells through activation of RhoA signaling and proteolytic activity. J Biol Chem 2011;205:1571-9.